- Q3 net sales grew 10.4% to $7.9B, while net income declined 1.2% to $318M (Adj. EBITDA up 11.8% to $1.0B)
- 9M net income fell 28.8% to $696M despite sales rising 10.9% to $22.9B
- Raised full-year net sales growth guidance to 10.0%-10.5% (prior 9.0%-10.0%); reaffirmed Adj. EBITDA at $3.3B-$3.4B
Signal #129135 · SEC 8-K
$MDLN SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $MDLN filing catalyst
Why did $MDLN trigger an AI stock catalyst alert?
$MDLN triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: Medline Reports Q3 Net Sales Up 10.4% to $7.9B, Raises FY26 Sales Guidance. Key points: - Q3 net sales grew 10.4% to $7.9B, while net income declined 1.2% to $318M (Adj. EBITDA up 11.8% to $1.0B) - 9M net income fell 28.8% to $696M despite sales rising 10.9% to $22.9B - Raised full-year net sales growth guidance to 10.0%-10.5% (prior 9.0%-10.0%); reaffirmed Adj. EBITDA at $3.3B-$3.4B
How did $MDLN stock react after the SEC filing?
After the SEC 8-K for $MDLN, observed market reaction: T0 price $34.09. Past moves do not guarantee future results.
Where can I get real-time $MDLN SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $MDLN via Telegram and the VIP Web Terminal from €10/month.